Trials / Completed
CompletedNCT03509740
Intravenous Tramadol Versus Intravenous Paracetamol in Patients With Dysmenorrhea
Efficacy and Safety of Intravenous Tramadol Versus Intravenous Paracetamol for Relief of Acute Pain of Primary Dysmenorrhea: A Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
Patients presented with primary dysmenorrhea composed the study population. One gram paracetamol and 100 mg tramadol in 100 ml saline with a slow infusion were compared in ceasing dysmenorrhea in the emergency department
Detailed description
Patients over 18 years old who presented with dysmenorrhea composed the study population. Patients received painkiller within the last six hours, physical findings consistent with peritoneal irritation, allergy to the study drugs, renal or liver failure, drug addiction, pregnancy or woman with lactation and denied to give inform consent were the exclusion criteria. The pain of the study patients is measured with the visual analogue scale at baseline, 15th and 30th minutes and 1 hour after study drug administration. At the end of the 60 minutes, rescue drug need is also recorded.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | tramadol | 100 mg tramadol in 100 ml saline with slow infusion |
| DRUG | paracetamol | Intravenous 1 gm paracetamol in 100 ml saline with slow infusion |
Timeline
- Start date
- 2018-04-25
- Primary completion
- 2018-10-01
- Completion
- 2018-10-20
- First posted
- 2018-04-26
- Last updated
- 2020-06-16
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03509740. Inclusion in this directory is not an endorsement.